Automate Your Wheel Strategy on CVS
With Tiblio's Option Bot, you can configure your own wheel strategy including CVS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CVS
- Rev/Share 310.5469
- Book/Share 57.6123
- PB 1.3369
- Debt/Equity 1.121
- CurrentRatio 0.8319
- ROIC 0.0043
- MktCap 97530497823.0
- FreeCF/Share 4.959
- PFCF 15.4983
- PE 207.8833
- Debt/Assets 0.3202
- DivYield 0.0346
- ROE 0.0062
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | CVS | Goldman | -- | Buy | -- | $91 | Oct. 14, 2025 |
| Upgrade | CVS | UBS | Neutral | Buy | -- | $79 | Aug. 18, 2025 |
| Upgrade | CVS | Robert W. Baird | Neutral | Outperform | -- | $82 | Aug. 14, 2025 |
| Upgrade | CVS | Leerink Partners | Market Perform | Outperform | $55 | $75 | Feb. 13, 2025 |
| Upgrade | CVS | Cantor Fitzgerald | Neutral | Overweight | -- | -- | Feb. 12, 2025 |
| Upgrade | CVS | Edward Jones | Hold | Buy | -- | -- | Jan. 30, 2025 |
| Upgrade | CVS | Deutsche Bank | Hold | Buy | -- | $66 | Dec. 3, 2024 |
| Upgrade | CVS | Barclays | Equal Weight | Overweight | $63 | $82 | Oct. 10, 2024 |
| Upgrade | CVS | TD Cowen | Hold | Buy | $59 | $85 | Oct. 4, 2024 |
News
CVS Health Care Delivery: Will the Growth Momentum Last in Q2?
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS' Health Care Delivery unit posts strong growth from Signify and Oak Street, but rising medical costs pose a near-term risk.
Read More
Buy CVS Stock Ahead of Its Upcoming Earnings?
Published: July 30, 2025 by: Forbes
Sentiment: Neutral
CVS Health (NYSE:CVS) is scheduled to announce its earnings on Thursday, July 31, 2025. For event-driven traders, analyzing the stock's historical behavior around earnings releases can provide valuable context.
Read More
Here's Why CVS Health (CVS) is a Strong Value Stock
Published: July 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Visa, CVS, and 4 More Oversold Stocks Worth a Look Before Earnings
Published: July 25, 2025 by: Barrons
Sentiment: Positive
Stocks that have gained too much are more susceptible to big drops than companies that dropped heading into their results.
Read More
CVS or DHR: Which Is the Better Value Stock Right Now?
Published: July 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical Services stocks are likely familiar with CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
Read More
CVS Health (CVS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Published: July 24, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Published: July 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Read More
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Read More
Here's Why CVS Health (CVS) is Poised for a Turnaround After Losing 7.7% in 4 Weeks
Published: July 22, 2025 by: Zacks Investment Research
Sentiment: Neutral
CVS Health (CVS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Read More
5 Low Price-to-Book Stocks That Should Be in Your Portfolio Now
Published: July 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Low P/B stocks like CVS, SIG, KB, AMG and PAGS are flashing value signals with strong EPS growth projections and solid fundamentals.
Read More
Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?
Published: July 18, 2025 by: Zacks Investment Research
Sentiment: Neutral
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
CVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?
Published: July 18, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.
Read More
Most Managed Care Insurers Expected To See Q2 2025 Drops In Revenue, Net Income
Published: July 17, 2025 by: Seeking Alpha
Sentiment: Negative
A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2, according to an S&P Global Market Intelligence analysis of sell-side analyst forecasts. Of the eight largest publicly traded US managed care insurers, all but two — UnitedHealth Group and Alignment Healthcare — are projected to report lower revenue compared with Q1 2025, while all eight are forecast to log higher revenue than Q2 2024. In Q2, all eight of the largest publicly traded US managed care insurers, except The Cigna Group, are expected to log lower net income sequentially, …
Read More
CVS Health - Q2 Earnings Are A Referendum On Future Of Company
Published: July 16, 2025 by: Seeking Alpha
Sentiment: Positive
CVS has transformed from a retail pharmacy to a complex healthcare conglomerate, but its stock price has remained stagnant over the past decade. The Medicare Advantage business, once seen as a growth engine, has become less profitable, leading to management shakeups and activist investor intervention. Despite a short-term recovery in 2025, CVS faces ongoing challenges: declining retail, regulatory threats to PBM, and uncertain Medicare Advantage profitability.
Read More
4 Value Stocks to Buy as Inflation and Market Volatility Rise
Published: July 16, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health, Hudbay Minerals, Universal Health Services and ASB stand out as value stocks amid rising inflation.
Read More
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Published: July 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
Here's Why CVS Health (CVS) is a Strong Value Stock
Published: July 09, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Is CVS Moving Closer to Reaching Its Long-Term Low 3X Leverage Goal?
Published: July 09, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health inches closer to its long-term leverage target, helped by Aetna margin recovery and disciplined cash use.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: July 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Read More
CVS Health declares quarterly dividend
Published: July 07, 2025 by: PRNewsWire
Sentiment: Neutral
WOONSOCKET, R.I. , July 7, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation.
Read More
Can CVS Sustain Pharmacy & Consumer Wellness Gains Through Year-End?
Published: July 04, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health's CVS Pharmacy and Consumer Wellness (“PCW”) segment has seen steady growth in recent months, with revenues up 11.1% year over year in the first quarter of 2025. Performance was supported by seasonal trends, including the impact of high vaccine demand and a longer-than-usual flu season.
Read More
CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Negative
CVS Health (CVS) closed at $66.6 in the latest trading session, marking a -4.28% move from the prior day.
Read More
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
4 Value Stocks to Invest in for the Second-Half 2025 Market Shift
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Hudbay, StoneCo, Centene, and CVS stand out as top value picks for H2 2025 with strong cash flow and growth prospects.
Read More
Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Negative
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
5 Low Price-to-Book Value Stocks to Buy in July for Solid Returns
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Positive
The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, ODP, STNE and PSFE are some such stocks.
Read More
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Read More
CVS drops Lilly's Zepbound
Published: July 01, 2025 by: CNBC Television
Sentiment: Negative
CNBC's Angelica Peebles reports on news regarding CVS.
Read More
These are the best-performing stocks of H1 2025
Published: July 01, 2025 by: Finbold
Sentiment: Positive
With the first half of 2025 now behind us, the stock market has seen its share of volatility.
Read More
Will CVS Health's Formulary Move Boost Its Weight Management Program? (Revised)
Published: June 30, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.
Read More
About CVS Health Corporation (CVS)
- IPO Date 1996-11-20
- Website https://www.cvshealth.com
- Industry Medical - Healthcare Plans
- CEO J. David Joyner
- Employees 219000